GL

Gongati Laxminarsimhareddy

Active Director Director DIN 09097117
DIN 09097117 First appointment Mar 2021 Primary industry Food And Beverages
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Gongati Laxminarsimhareddy

Data last updated:

Gongati Laxminarsimhareddy is a Director at Slaven Pharmaceuticals Private Limited (since 2021). The company operates in Food And Beverages.

DIN 09097117
Primary Designation Director
Industry Food And Beverages
First Appointment 08 Mar 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 Mar 20212021Active

Directorship timeline

Open interactive timeline →
Slaven Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Gongati Laxminarsimhareddy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gongati Laxminarsimhareddy

Gongati Laxminarsimhareddy currently holds 1 directorship: Slaven Pharmaceuticals Private Limited (Director, since 08 Mar 2021).

Gongati Laxminarsimhareddy was first appointed on 08 Mar 2021 as Director at Slaven Pharmaceuticals Private Limited.

The current boards of Gongati Laxminarsimhareddy's companies include Annayyagari Vikram (Slaven Pharmaceuticals Private Limited), Chintapanti Ashok Reddy (Slaven Pharmaceuticals Private Limited), Lokanatha Reddy Buchi Reddy (Slaven Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available